Flutamide-induced cytotoxicity and oxidative stress in an in vitro rat hepatocyte system

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Maruf, Abdullah Al ^a   O'Brien, Peter ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IN-VITRO; RAT HEPATOCYTES;

ACETYLCYSTEINE; BIPHENYL; FERROUS ION; FLUTAMIDE; GLUCOSE OXIDASE; GLUTATHIONE; HYDROGEN PEROXIDE; N,N' DIPHENYL 1,4 PHENYLENEDIAMINE; PEROXIDASE; PROPYLTHIOURACIL; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE DISMUTASE; TROLOX C; AMINE OXIDE; ANTIANDROGEN; ANTIOXIDANT; SPIN LABELING; TEMPOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; INFLAMMATION; LIPID PEROXIDATION; LIVER CELL; LIVER TOXICITY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; DRUG EFFECTS; DRUG INTERACTION; HUMAN; METABOLISM; SPIN LABELING; SPRAGUE DAWLEY RAT;

ANDROGEN ANTAGONISTS; ANIMALS; ANTIOXIDANTS; CYCLIC N-OXIDES; DRUG INTERACTIONS; FLUTAMIDE; HEPATOCYTES; HUMANS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SPIN LABELS;

EID: 84908354928     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/398285     Document Type: Article

References (47)

1. Steinsapir J., Mora G., Muldoon T. G., Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor. Biochimica et Biophysica Acta-Molecular Cell Research 1991 1094 1 103 112 10.1016/0167-4889(91)90031-R 2-s2.0-0025807069
2. Gomez J.-L., Dupont A., Cusan L., Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. The American Journal of Medicine 1992 92 5 465 470 10.1016/0002-9343(92)90741-S 2-s2.0-0026594568
3. Berson A., Wolf C., Chachaty C., Fisch C., Fau D., Eugene D., Loeper J., Gauthier J.-C., Beaune P., Pompon D., Maurel P., Pessayre D., Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies. Journal of Pharmacology and Experimental Therapeutics 1993 265 1 366 372 2-s2.0-0027373878
4. Asakawa N., Studies on the metabolic fate of flutamide (4): biliary excretion, enterohepatic circulation, absorption from gastro-intestinal tract, metabolism and drug-metabolizing enzymes induction in rats. Xenobiotic Metabolism and Disposition 1995 10 470 483
5. Wang H.-X., Ma X.-C., Deng Q.-L., Li D., Cytotoxicity of flutamide and 2-hydroxyflutamide and their effects on CYP1A2 mRNA in primary rat hepatocytes. Acta Pharmacologica Sinica 2002 23 6 562 566 2-s2.0-0036276743
6. Fau D., Eugene D., Berson A., Letteron P., Fromenty B., Fisch C., Pessayre D., Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. Journal of Pharmacology and Experimental Therapeutics 1994 269 3 954 962 2-s2.0-0028240927
7. Hart W., Stricker B. H., Flutamide and hepatitis. Annals of Internal Medicine 1989 110 11 943 944 2-s2.0-0024349651
8. McDonnell N. D., Livingston R. B., Severe reversible neutropenia following treatment of prostate cancer with flutamide. Journal of Urology 1994 151 5 1353 1354 2-s2.0-0028326101
9. Srinivasan R., Buchweitz J. P., Ganey P. E., Alteration by flutamide of neutrophil response to stimulation: implications for tissue injury. Biochemical Pharmacology 1997 53 8 1179 1185 10.1016/S0006-2952(97)00099-3 2-s2.0-0030993242
10. MacAllister S. L., Maruf A. A., Wan L., Chung E., O'Brien P., Modeling xenobiotic susceptibility to hepatotoxicity using an in vitro oxidative stress inflammation model. Canadian Journal of Physiology and Pharmacology 2013 91 3 236 240 10.1139/cjpp-2012-0255 2-s2.0-84875490299
11. Ganey P. E., Roth R. A., Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents. Toxicology 2001 169 3 195 208 10.1016/S0300-483X(01)00523-6 2-s2.0-0035965951
12. Pérez-Matute P., Zulet M. A., Martínez J. A., Reactive species and diabetes: counteracting oxidative stress to improve health. Current Opinion in Pharmacology 2009 9 6 771 779 10.1016/j.coph.2009.08.005 2-s2.0-70449469039
13. Ma Q., Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacology and Therapeutics 2010 125 3 376 393 10.1016/j.pharmthera.2009.11.004 2-s2.0-77049114949
14. Riechelmann H., Cellular and molecular mechanisms in environmental and occupational inhalation toxicology. GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery 2004 3
15. Tafazoli S., Spehar D. D., O'Brien P. J., Oxidative stress mediated idiosyncratic drug toxicity. Drug Metabolism Reviews 2005 37 2 311 325 10.1081/DMR-200055227 2-s2.0-18744364709
16. O'Brien P. J., Siraki A. G., Accelerated cytotoxicity mechanism screening using drug metabolising enzyme modulators. Current Drug Metabolism 2005 6 2 101 109 10.2174/1389200053586082 2-s2.0-15444381338
17. Maruf A. A., Wan L., O'Brien P. J., Evaluation of azathioprine-induced cytotoxicity in an in vitro rat hepatocyte system. BioMed Research International 2014 2014 7 379748 10.1155/2014/379748
18. MacAllister S. L., Young C., Guzdek A., Zhidkov N., O'Brien P. J., Molecular cytotoxic mechanisms of chlorpromazine in isolated rat hepatocytes. Canadian Journal of Physiology and Pharmacology 2013 91 1 56 63 10.1139/cjpp-2012-0223 2-s2.0-84873595224
19. Tafazoli S., O'Brien P. J., Accelerated cytotoxic mechanism screening of hydralazine using an in vitro hepatocyte inflammatory cell peroxidase model. Chemical Research in Toxicology 2008 21 4 904 910 10.1021/tx700371x 2-s2.0-43149087329
20. Tafazoli S., O'Brien P. J., Amodiaquine-induced oxidative stress in a hepatocyte inflammation model. Toxicology 2009 256 1-2 101 109 10.1016/j.tox.2008.11.006 2-s2.0-58149230995
21. Chan K., Lehmler H.-J., Sivagnanam M., Feng C. Y., Robertson L., O'Brien P. J., Cytotoxic effects of polychlorinated biphenyl hydroquinone metabolites in rat hepatocytes. Journal of Applied Toxicology 2010 30 2 163 171 10.1002/jat.1483 2-s2.0-77249124390
22. Olfert E., Cross B., McWilliam A., Guide to the Care and Use of Experimental Animals 1993 1st Ottawa, Canada Canadian Council on Animal Care
23. Moldéus P., Högberg J., Orrenius S., Isolation and use of liver cells. Methods in Enzymology 1978 52 60 71 10.1016/S0076-6879(78)52006-5 2-s2.0-0017833187
24. Lee E., Miki Y., Katsura H., Kariya K., Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochemical Pharmacology 1990 39 9 1467 1471 10.1016/0006-2952(90)90428-N 2-s2.0-0025276234
25. Possel H., Noack H., Augustin W., Keilhoff G., Wolf G., 2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Letters 1997 416 2 175 178 10.1016/S0014-5793(97)01197-6 2-s2.0-0030732696
26. Smith M. T., Thor H., Hartzell P., Orrenius S., The measurement of lipid peroxidation in isolated hepatocytes. Biochemical Pharmacology 1982 31 1 19 26 10.1016/0006-2952(82)90230-1 2-s2.0-0020058754
27. Bulteau A. L., Planamente S., Jornea L., Dur A., Lesuisse E., Camadro J. M., Auchère F., Changes in mitochondrial glutathione levels and protein thiol oxidation in Δyfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia. Biochimica et Biophysica Acta: Molecular Basis of Disease 2012 1822 2 212 225 10.1016/j.bbadis.2011.11.003 2-s2.0-83255165402
28. Andersson B. S., Aw T. Y., Jones D. P., Mitochondrial transmembrane potential and pH gradient during anoxia. American Journal of Physiology-Cell Physiology 1987 252 4 349 355 2-s2.0-0023240626
29. Brown K. E., Brunt E. M., Heinecke J. W., Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver. The American Journal of Pathology 2001 159 6 2081 2088 10.1016/S0002-9440(10)63059-3 2-s2.0-0035190154
30. Kato A., Yoshidome H., Edwards M. J., Lentsch A. B., Regulation of liver inflammatory injury by signal transducer and activator of transcription-6. American Journal of Pathology 2000 157 1 297 302 10.1016/S0002-9440(10)64540-3 2-s2.0-0033869941
31. Tafazoli S., O'Brien P. J., Peroxidases: a role in the metabolism and side effects of drugs. Drug Discovery Today 2005 10 9 617 625 10.1016/S1359-6446(05)03394-5 2-s2.0-18944406318
32. Zatón A. M. L., Ochoa de Aspuru E., Horseradish peroxidase inhibition by thiouracils. FEBS Letters 1995 374 2 192 194 10.1016/0014-5793(95)01088-V 2-s2.0-0028822876
33. Klebanoff S. J., Waltersdorph A. M., Inhibition of peroxidase-catalyzed reactions by deferoxamine. Archives of Biochemistry and Biophysics 1988 264 2 600 606 10.1016/0003-9861(88)90326-8 2-s2.0-0023680875
34. Chan K., Jensen N. S., Silber P. M., O'Brien P. J., Structure-activity relationships for halobenzene induced cytotoxicity in rat and human hepatoctyes. Chemico-Biological Interactions 2007 165 3 165 174 10.1016/j.cbi.2006.12.004 2-s2.0-33846881820
35. O'Brien P. J., Chan K., Silber P. M., Human and animal hepatocytes in vitro with extrapolation in vivo. Chemico-Biological Interactions 2004 150 1 97 114 10.1016/j.cbi.2004.09.003 2-s2.0-7444245666
36. Rosman A. S., Frissora-Rodeo C., Marshall A. T., Reiter B. P., Paronetto F., Cholestatic hepatitis following flutamide. Digestive Diseases and Sciences 1993 38 9 1756 1759 10.1007/BF01303188 2-s2.0-0027291059
37. Pessayre D., Larrey D., McIntyre N., Benhamou J., Bircher J., Rizzeto M., Rodes J., Drug-induced liver injury. Oxford Textbook of Clinical Hepatology 1991 2nd Oxford, UK Oxford University Press 875 902
38. Núnez-Vergara L. J., Farias D., Bollo S., Squella J. A., An electrochemical evidence of free radicals formation from flutamide and its reactivity with endo/xenobiotics of pharmacological relevance. Bioelectrochemistry 2001 53 1 103 110 10.1016/S0302-4598(00)00126-4 2-s2.0-0035184808
39. Kashimshetty R., Desai V. G., Kale V. M., Lee T., Moland C. L., Branham W. S., New L. S., Chan E. C. Y., Younis H., Boelsterli U. A., Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity. Toxicology and Applied Pharmacology 2009 238 2 150 159 10.1016/j.taap.2009.05.007 2-s2.0-67349231918
40. Zafarullah M., Li W. Q., Sylvester J., Ahmad M., Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences 2003 60 1 6 20 10.1007/s000180300001 2-s2.0-0037278466
41. Kang P., Dalvie D., Smith E., Zhou S., Deese A., Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes. Drug Metabolism and Disposition 2007 35 7 1081 1088 10.1124/dmd.107.014860 2-s2.0-34250698951
42. Hamad I., Arda N., Pekmez M., Karaer S., Temizkan G., Intracellular scavenging activity of Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) in the fission yeast, Schizosaccharomyces pombe. Journal of Natural Science, Biology and Medicine 2010 1 1 16 21 10.4103/0976-9668.71667 2-s2.0-84872583703
43. Leonard S. S., Xia C., Jiang B.-H., Stinefelt B., Klandorf H., Harris G. K., Shi X., Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochemical and Biophysical Research Communications 2003 309 4 1017 1026 10.1016/j.bbrc.2003.08.105 2-s2.0-0141788133
44. Zini R., Morin C., Bertelli A., Bertelli A. A. E., Tillement J.-P., Effects of resveratrol on the rat brain respiratory chain. Drugs under Experimental and Clinical Research 1999 25 2-3 87 97 2-s2.0-0033065221
45. Di Luzio N. R., Costales F., Inhibition of the ethanol and carbon tetrachloride induced fatty liver by antioxidants. Experimental and Molecular Pathology 1965 4 2 141 154 10.1016/0014-4800(65)90030-4 2-s2.0-0000196027
46. Kagan V. E., Jiang J., Bayir H., Stoyanovsky D. A., Targeting nitroxides to mitochondria: location, location, location, and.concentration. Highlight Commentary on 'Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide'. Free Radical Biology and Medicine 2007 43 3 348 350 10.1016/j.freeradbiomed.2007.03.030 2-s2.0-34250893755
47. Vaz S. M., Augusto O., Inhibition of myeloperoxidase-mediated protein nitration by tempol: kinetics, mechanism, and implications. Proceedings of the National Academy of Sciences of the United States of America 2008 105 24 8191 8196 10.1073/pnas.0708211105 2-s2.0-46149125703